Anti-androgens
Drug Safety Update
December 2014: Cyproterone acetate with ethinylestradiol (co-cyprindiol): balance of benefits and risks remains positive.
December 2014: High-dose cyproterone acetate: potential risk of (multiple) meningiomas.
June 2020: Cyproterone acetate: new advice to minimise risk of meningioma
Increased risk of venous thromboembolism
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary